STERLING, Kan. Genzada Pharmaceuticals, LLC, Monday announced its plans for headquarters in Sterling, a project expected to add as many as 25 to 30 new jobs.
Specifically Monday, the company announced plans for corporate headquarters and new office space to accommodate growth and expansion plans. The City of Sterling says a new, nearly 10,000 square-foot facility is slated for completion in 2017 at 101 S. Broadway in Sterling.
The company also has a 1,800 square-foot facility in Sterling that, once remodeled, will serve as a research-and-development and small-scale manufacturing laboratory, the city says.
"The new space will allow us to continue to expand on achieving our mission, which is to eliminate diseases that induce human suffering,” says Genzada Executive Vice President Jason West.
West says Genzada is seeking FDA approval for various pharmaceutical products for rare and hard-to-treat cancers and other medical conditions.
He says the move represents its "commitment to continue its partnership with the City of Sterling, Rice County and the State of Kansas."
U.S. Sen. Jerry Moran described Genzada's plans in Sterling as "great news for Central Kansas."
“Genzada’s decision to expand their presence creates new jobs for Kansans who will have the joy of knowing they are working to improve the health of those around them and save lives," Moran says. "Genzada also represents an important investment in the community.”
A groundbreaking for the company's new headquarters is set for 10:30 a.m. Oct. 14 at the corner of S. Broadway and Main Street in Sterling.
For more information on Genzada, you can contact the company through its WEBSITE.